Daniel Gedeon Teper

Daniel Gedeon Teper discloses dealings in Immune Pharmaceuticals Inc to SEC (Form 4). The record holds 15 filings, for trades running from 25 August 2013 to 6 October 2016.

On the market, this insider has only ever bought: 12 purchases, €920k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 1 share grant and 1 option exercise. 2016 to date brings 6 purchases and no sales.

A typical purchase (the median) is worth €23k. On 2 out of 6 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The record was last updated on 11 October 2016 with an option exercise (€6,657) in Immune Pharmaceuticals Inc. The clock since the last published purchase (19 August 2016) now reads 3,718 days. Half of the filings or more reach the SEC (Form 4) feed on the day of the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.